HF
HARP

HRT Financial’s Harpoon Therapeutics, Inc. Common Stock HARP Stock Holding History

HRT Financial’s Portfolio HARP Stock Details HARP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,089
Closed -$7K – 3387
2023
Q2 		$7K Buy
+1,089
New +$7.53K ﹤0.01% 2211
2022
Q3 		– Sell
-1,078
Closed -$20K – 3736
2022
Q2 		$20K Buy
+1,078
New +$27.9K ﹤0.01% 2608
2021
Q4 		– Sell
-7,780
Closed -$614K – 4345
2021
Q3 		$614K Buy
+7,780
New +$782K ﹤0.01% 1800
2021
Q1 		– Sell
-1,133
Closed -$188K – 3295
2020
Q4 		$188K Buy
+1,133
New +$175K ﹤0.01% 1509

Other funds holding HARP

MB
MPM BioImpact Boston, Massachusetts $1.29B AUM 141.72% 1-Year Est. Return
NLVP
New Leaf Venture Partners New York $43M AUM 25.55% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
SCM
Sio Capital Management New York $697M AUM 79.73% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

HRT Financial's HARP Position: Q3 2023 in Review

HRT Financial sold out of Harpoon Therapeutics, Inc. Common Stock (HARP) in Q3 2023, closing a stake of 1,089 shares — an estimated $7K sold.

HRT Financial first reported a position in HARP in Q4 2020 and held it in 4 quarters. The position peaked at $614K in Q3 2021. 32 funds tracked by Wall St. Rank hold HARP as of Q3 2023.

  • HRT Financial reported no remaining Harpoon Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • HRT Financial sold 1,089 Harpoon Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $7K.
  • HRT Financial first reported a position in Harpoon Therapeutics, Inc. Common Stock in Q4 2020 and held it in 4 quarters.
  • HRT Financial's Harpoon Therapeutics, Inc. Common Stock position peaked at $614K in Q3 2021.
  • 32 funds tracked by Wall St. Rank held Harpoon Therapeutics, Inc. Common Stock as of Q3 2023.

Based on HRT Financial's 13F filing for Q3 2023, filed 13 Nov 2023.